The present work was undertaken to study the effect of bacterial lipopolysaccharide (LPS), a potent activator of the host inflammatory response, on the synthesis of nerve growth factor (NGF) by newborn rat brain astrocytes. Treatment of primary rat astroglial cells cultured in chemically defined med
Regulation of growth factor induced gene expression by calcium signalling: Integrated mRNA and protein expression analysis
β Scribed by Rosalind E. Jenkins; Shaun R. Hawley; Waraporn Promwikorn; Jennifer Brown; Jane Hamlett; Stephen R. Pennington
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 189 KB
- Volume
- 1
- Category
- Article
- ISSN
- 1615-9853
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Cytoskeleton not only controls cell morphology but also regulates cell growth, migration, differentiation, and gene expression, events which are fundamental to embryogenesis, carcinogenesis, and wound healing. We have recently reported that reorganization of cytoskeleton induces expression of mRNA f
Background. Angiogenesis is crucial for tumor growth and metastasis. In several tumors, microvascular density has been shown to correlate with metastasis and aggressiveness. Basic fibroblast growth factor (bFGF) has potent angiogenic activity and has been identified in a wide variety of malignancies
## Abstract TGFβΞ² (transforming growth factorβbeta) plays a key role in osteoblast differentiation and bone development. While the ability of TGFβΞ² to inhibit the expression of osteoblast differentiation genes has been well documented, the mechanism of this inhibition is not yet completely characte
## Abstract Parathyroid hormone (PTH) regulates bone remodeling and calcium homeostasis by acting on osteoblasts. Recently, the gene expression profile changes in the rat PTH (1β34, 10^β8^M)βtreated rat osteoblastic osteosarcoma cell line, UMR 106β01, using DNA microarray analysis showed that mRNA
Signal transduction initiated by TGFb1 and OP-1 was studied in MG63 human osteosarcoma cells and in normal human bone cells (HBCs) in the presence of inhibitors of signal transduction events, using insulinlike growth factor binding protein-3 (IGFBP-3) production as an end point. Treatment of serum-f